Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Cancer Research UK
Essen Biotech
University of Nebraska
Adela, Inc
Mayo Clinic
Cancer Research UK
Incyte Corporation
Barbara Ann Karmanos Cancer Institute
Cedars-Sinai Medical Center
Universidade Federal de Pernambuco
Taproot Health
Cedars-Sinai Medical Center
Celgene
Novartis
Celgene
Celgene
Rutgers, The State University of New Jersey
Northwestern University
Kartos Therapeutics, Inc.
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Celgene
GlaxoSmithKline
Shenzhen BinDeBio Ltd.
Vanderbilt-Ingram Cancer Center
City of Hope Medical Center
CureOne
Vanderbilt-Ingram Cancer Center
Leaf Vertical Inc.
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
University of Louisville
OHSU Knight Cancer Institute
Ohio State University Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Rutgers, The State University of New Jersey
Shenzhen Second People's Hospital
M.D. Anderson Cancer Center
Barbara Ann Karmanos Cancer Institute
Stanford University
City of Hope Medical Center
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)
Vanderbilt University